Bio-implants Market Forecast to 2031 - Growth, Size, Share
分析师观点：
该报告根据当前生物植入物市场趋势和影响生物植入物市场的驱动因素介绍了增长前景市场增长的生物植入物。导致生物植入物市场规模不断增长的主要因素包括慢性病病例的增加（特别是老年人口）以及可支配收入的增加。发达国家和发展中国家的医疗基础设施预计将进一步改善，从而显着推动生物植入物市场。
全球人口对美容植入物的有效性和技术进步的认识有所提高。由于牙齿问题病例的增加，生物植入物市场在全球范围内不断增长。由于心血管和骨科问题的发病率不断上升，对骨科植入物和起搏器的需求也在增加。由于北美地区医疗保健基础设施健全、人们对美容植入物的认识不断提高以及该地区生物植入物市场的主要参与者，生物植入物控制的整体销售额预计将增长。此外，由于医疗保健技术的快速进步、对非侵入性生物植入物的需求增加以及老年人口的激增，欧洲成为世界第二大生物植入物市场。然而，生物植入手术成本的增加和生物植入产品的适当利用阻碍了生物植入市场的增长。
市场概述：
促进生物植入市场增长的关键因素包括老年人骨质疏松的病例、对微创手术的需求不断增长以及生活方式障碍病例的增加。此外，医疗保健技术的发展预计将对未来几年的生物植入市场预测产生重大影响。尽管医疗保健行业多年来取得了显着的技术进步，但严重疾病发病率的上升阻碍了生物植入物的市场。
市场驱动力：
< br>日益增加的生活方式障碍负担推动市场增长
糖尿病、心血管疾病和骨关节炎等生活方式障碍在全球范围内变得越来越普遍，是发病率和死亡率的主要原因。支架和支架等生物植入物可以治疗这些疾病，并且正在成为传统永久植入物的有吸引力的替代品。根据美国心脏协会2021年发表的一篇文章，美国每年约有4万名儿童接受先天性心脏病手术。英国心脏基金会2022年发布的《2022年1月英国概况》指出，到2021年，约有760万人患有心脏病和循环系统疾病，其中近400万男性和360万女性患有心脏病和循环系统疾病。心血管疾病的流行导致对早期诊断和治疗的需求不断增加，预计这将推动对介入心脏病学手术以及心血管植入物生物植入物的需求。此外，口腔健康问题的惊人增加预计将增加对生物植入物的需求。例如，根据世界卫生组织（WHO）2021年全球疾病负担研究，口腔疾病预计将影响世界上约一半的人口。大约有 35.8 亿人受到龋齿和其他牙齿问题的影响。生物植入物
此外，生物植入物有助于管理和控制肌肉骨骼疾病等疾病中的特定药物输送。据《骨科杂志》2021年1月发表的文章显示，北京社区中年人腰椎滑脱症总体患病率为17.26%（男性15.98%，女性18.80%）。 60岁以上的女性更容易患腰椎滑脱症。据世界卫生组织称，肌肉骨骼损伤和疾病非常普遍，影响着全世界 17.1 亿人，是导致全世界残疾的主要原因。根据《柳叶刀风湿病学》发表的一项新研究，到 2050 年，预计将有超过 10 亿人患有关节、肌肉、骨骼、韧带、肌腱和脊柱疾病，而 2020 年这一数字约为 5 亿。由于人口老龄化，患有肌肉骨骼疾病和相关功能限制的人数正在迅速增加。患者肌肉骨骼状况的不断增长导致对更多植入手术和住院治疗的需求增加，从而推动了生物植入物市场。
细分分析：
生物植入物市场分析已经进行通过考虑以下细分市场：类型、材料和最终用户。
根据类型，生物植入物市场分为心血管植入物、骨科植入物、牙科植入物、眼科植入物等。心血管植入物细分市场在 2023 年占据更大的市场份额。该细分市场的增长归因于开发新型心脏植入物产品的研发活动的快速增长。例如，2022 年 2 月，医疗技术公司雅培 (Abbott) 宣布全球首例患者植入无引线双腔起搏器系统，作为其 AVEIR DR i2i 关键临床试验的一部分。雅培实验性双腔无引线起搏器的植入代表了无引线起搏器技术的一个重要技术里程碑；这是世界上第一个进行关键试验的项目。
生物植入物市场根据材料分为金属、陶瓷和聚合物。速释胶囊细分市场在 2023 年占据最大的市场份额。预计在预测期内复合年增长率最高。这些金属具有卓越的机械强度、耐腐蚀性和生物相容性，是植入应用的理想选择。钛因其卓越的耐用性、轻量化设计以及与人体组织的兼容性而成为骨科、牙科和心血管植入物中极受欢迎的材料。由于其延展性、导电性和惰性，金属在心脏电极和神经探针等专门植入应用中受到重视。慢性病发病率的增加以及材料科学和制造技术的进步推动了生物植入物中对生物材料金属的需求。这巩固了生物材料金属作为生物植入市场最受欢迎的材料类别的地位。
根据最终用户，市场分为医院和诊所以及门诊手术中心。医院和诊所细分市场在 2023 年将占据更大的生物植入市场份额，预计 2023 年至 2031 年期间复合年增长率将更高。医院和诊所因其广泛的医疗项目和多学科的患者护理方法而经常吸引大量患者，包括那些需要专门种植治疗的患者。医院通常与研究中心和医疗设备制造商合作，以促进获得尖端的植入突破和技术。医院和诊所是生物植入市场的重要参与者，因为它们提供必要的植入相关服务，并对与生物植入相关的商品和工艺产生巨大需求。因此，随着人们对药物的需求不断增长，医院和诊所数量的不断增加预计将在预测期内支持该细分市场的增长。
区域分析：
生物植入物市场报告的范围包括北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。 2023年北美市场估值为505.1亿美元，预计到2031年将达到966.9亿美元；预计 2023 年至 2031 年复合年增长率为 8.5%。北美市场分为美国、加拿大和墨西哥。北美市场的增长归因于慢性病患病率的增加和医疗基础设施的改善。 2022 年 7 月，美国疾病控制与预防中心 (CDC) 的最新数据显示，冠状动脉疾病是最常见的心脏病类型之一，在美国约有 2010 万 20 岁及以上的成年人患有这种疾病。另外，根据CDC数据，每40秒就有一个人心脏病发作，即近80.5万人。慢性病数量的增加预计将增加预测期内对生物植入物的总体需求。
根据医疗保险和医疗补助服务中心的数据，预计到 2020 年国家医疗保健支出将达到 6.2 万亿美元到 2028 年，2019 年至 2028 年平均年增长率 (AAR) 为 5.4%。由于国家医疗保健支出预计将增长 1.1%，预计 2028 年医疗保健占经济的比重将增长 19.7%，快于2019-2028 年平均 GDP。因此，医疗保健支出的增加预计将为市场参与者在预测期内开发生物植入物创造机会。
到 2023 年，欧洲将占据第二大生物植入物市场份额。该地区的原因在于医疗保健技术的进步、对非手术生物植入物的需求增加以及老年人口的增长。欧洲市场的增长归因于政府对医疗保健的资助和支持、骨科疾病发病率的增加以及医疗保健领域研发活动的增加。此外，由于该地区心血管疾病发病率的增加，心血管手术数量的增加正在推动该地区的生物植入市场。
预计亚太地区的复合年增长率将是全球最高的2023-2031 年生物植入物市场。该地区的市场增长归因于老年人口的增长、可支配收入的增加、医疗保健投资的增加和市场参与者的扩张，以及由于交通事故数量的增加而导致的脊髓损伤病例的增加。亚太地区正在经历显着增长，特别是在中国和印度等新兴市场。扩大医疗基础设施和增加该领域的投资以提供高效的患者服务推动了该地区的生物植入市场。例如，根据日本庆应义塾大学 2019 年的一份出版物，日本约有 10 万名患者因脊髓损伤而瘫痪。然而，iPS 技术的批准预计将在不久的将来帮助该国的这些患者，这可能会在未来几年为生物植入市场提供机会。据联合国亚洲经济社会委员会和太平洋社会发展部统计，2016年，亚洲超过12.4%的人口年龄在60岁以上，预计到2050年底这一数字将达到13亿.
主要参与者分析：
LifeNet Health；史密斯与侄子； Arthrex 公司；莱曼尼克诊所；阿尔法生物技术公司； MiMedx 集团；美敦力；圣犹达医疗（雅培）；史赛克合作；德普合成公司； Biomet（齐默）； Exactech公司；科利耳有限公司；和 Straumann AG 是生物植入市场报告中介绍的主要参与者之一。
最新动态：
在市场上运营的公司采用并购等方式。根据该公司新闻稿，以下是最近的一些关键进展：
2023 年 2 月，旨在修复弯曲骨骨折的医疗设备开发商 CurvaFix, Inc. 宣布推出其较小直径的 7.5 mm—CurvaFix IM 植入体。它旨在简化手术程序，并在小骨头中提供牢固、稳定的固定，旨在使患者能够有骨头。2022 年 6 月，ZimVie 推出了美国食品和药物管理局，批准了 T3 专业设计的植入物，并在2021年6月，医疗器械公司Intelligent Implants Ltd.获得美国FDA授予的骨科植入技术SmartFuse突破性认证。 SmartFuse 平台旨在远程刺激、控制和监测骨骼生长，以做出实时临床决策。该产品适用于首次使用进行腰椎融合术的患者。2021年2月，美敦力推出了TYRX可吸收抗菌鞘，这是一种可吸收的一次性抗菌鞘，设计用于稳定心脏植入式电子设备或植入式神经刺激器。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The bio implants market is expected to be valued at US$ 223.06 billion in 2031.
The global bio implants market, based on type, the bio implants market is segmented into cardiovascular implants, orthopedic implants, dental implants, ophthalmic implants, and others. The cardiovascular implants segment held the largest bio implants market share in 2023; it is also expected to register the highest CAGR during 2023–2031. The bio implants market, based on material, is segmented into metals, ceramics, and polymers. The metals segment held the largest bio implants market share in 2023. It is further expected to register the highest CAGR from 2023 to 2031. Based on end user, the market is bifurcated into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment accounted for a larger market share in 2023. The same segment is anticipated to register a higher CAGR during 2023–2031.
The bio implants market majorly consists of the players such as LifeNet Health; Smith & Nephew; Arthrex, Inc.; Clinic Lemanic; Alpha Bio Tec; MiMedx Group; Medtronic; St Jude Medical (Abbott); Stryker Cooperation; DePuy Synthes; Biomet (Zimmer); Exactech, Inc.; Cochlear Ltd; and Straumann AG.
The factors driving the growth of the bio implants market include the increasing burden of lifestyle disorders and the growing demand for minimally invasive surgical procedures.
Bio implants are designed to repair the physiological function of a damaged biostructure. The implantation method replaces; supports; and improves a missing, damaged, or existing biological structure. The bio implants market report emphasizes the key factors impacting the market and showcases the developments of prominent players. Increasing incidences of bone loss in the geriatric population, growing demand for minimally invasive surgeries, rising cases of lifestyle disorders, and technological innovations in the healthcare sector are a few factors contributing to the growing bio implants market size. Further, increased R&D activities and aggressive strategies by leading competitors are driving the bio implants market. The high cost of bioimplant procedures and appropriate utilization of bioimplant products hamper the market growth.
The bio implants market was valued at US$ 117.82 billion in 2023.
The List of Companies - Bio Implants Market
- LifeNet Health
- Smith & Nephew
- Arthrex, Inc.
- Clinic Lemanic
- Alpha Bio Tec
- MiMedx Group
- Medtronic
- St Jude Medical (Abbott)
- Stryker Cooperation
- DePuy Synthes
- Biomet (Zimmer)
- Exactech, Inc.
- Cochlear Ltd
- Straumann AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For